Premio Breakthrough · Ciencias de la vida
Premio Breakthrough 2026: Ganadores
Destinatarios
-
Albert Maguire, Jean Bennett, Katherine A. High
For developing a therapy for inherited retinal degeneration that became the first FDA-approved gene therapy for a genetic disease.
-
Bryan Traynor, Rosa Rademakers
For the discovery of the most common genetic cause of ALS and frontotemporal dementia which charted the path for new mechanistic studies of these diseases.
-
Stuart H. Orkin, Swee Lay Thein
For elucidating the mechanism driving the switch from fetal to adult hemoglobin and validating it as a therapeutic target for sickle-cell disease and beta-thalassemia.